期刊文献+

肝硬化并发上消化道出血的危险因素分析 被引量:1

Analysis on Risk Factors of Cirrhosis Complicated Hemorrhage of Upper Digestive Tract
下载PDF
导出
摘要 目的:了解肝硬化并发消化道出血的相关危险因素,为预防和控制上消化道出血提供可靠的依据。方法:对150例肝硬化患者进行病例对照研究。结果:肝硬化并发上消化道出血与食道静脉曲张(OR=3.942,P=0.001),肝功能分级(OR=1.028,P=0.003),门脉高压性胃病(OR=3.862,P=0.002)有显著相关性。结论:肝硬化并发上消化道出血的危险因素是食道静脉曲张、肝功能分级及门脉高压性胃病。 Objective: To find out the related risk factors of cirrhosis complicated hemorrhage of upper digestive tract and provide reliable basis for preventing and controlling the disease. Methods:Case-control study was done on 150 patients with cirrhosis. Results: Cirrhosis complicated hemorrhage of upper digestive tract had prominently inter- ralations with the factors of esophageal varicosis(OR = 3.942, P = 0.001 ), liver function grade (OR = 1.028, P-= 0.003), portal venous high pressure stomach trouble (OR = 3.862, P = 0.002 ). Conclusion: Risk factors of cirrhosis complicated hemorrhage of upper digestive tract are esophageal varicosis, liver function grade and portal venous high pressure stomach trouble respectively.
作者 顾伟玲
出处 《山西职工医学院学报》 CAS 2006年第1期12-14,共3页 Journal of Shanxi Medical College for Continuing Education
关键词 肝硬化 门脉高压 上消化道出血 危险因素 cirrhosis portal venous high pressure hemorrhage of upper digestive tract risk factor
  • 相关文献

参考文献6

二级参考文献12

  • 1段丽萍 梁扩寰 等.门静脉高压症的内镜诊断.门静脉高压症[M].北京:人民卫生出版社,1999.277-283.
  • 2[1]Johanson JF, Siddique R, Damiano AM, Jokubaitis L,Murthy A, Bhattacharjya A. Rabeprazole improves healthelated quality of life in patients with erosive gastroesophageal reflux disease. Dig Dis Sci, 2002, 47: 2574~2578.
  • 3[2]Skoczylas T, Sarosiek l, Sostarich S, McElhinney C, Durham S, Sarosiek J. Significant enhancement of gastric mucin content after rabeprazole administration: its poten tial clinical significance in acid-related disorders. Dig DisSci, 2003, 48: 322~328.
  • 4[3]Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE Ⅱ: a severity of disease classification system. Crit Care Med, 1985, 13: 818~829.
  • 5[4]Ranson JH, Rifkind KM, Roses DF, Fink SD, Eng K, Spencer FC. Prognostic signs and the role of operative management in acute pancreatitis. Surg Gynecol Obstet, 1974, 139: 69~81.
  • 6[5]Balthazar EJ, Robinson DL, Megibow AJ, Ranson JH. Acute pancreatitis: value of CT in establishing prognosis. Radiology, 1990, 174: 331~336.
  • 7[6]Lin CK, Wang ZS, Lai KH, Lo GH, Hsu PI. Gastrointestinal mucosal lesions in patients with acute pancreati tis. Zhonghua Yi Xue Za Zhi (Taipei), 2002, 65: 275~ 278.
  • 8[7]Tryba M. Role of acid suppressants in intensive care medic ine. Best Pract Res Clin Gastroenterol, 2001, 15: 447~461.
  • 9[8]Steinberg KP. Stress-related mucosal disease in the crit ically ill patient: risk factors and strategies to prcvent stress-related bleeding in the intensive care unit. Crit Care Med, 2002, 30 (6 Suppl): S362~S364.
  • 10[9]Freedman MD. Stress ulcer prevention and histamine-2 receptor antagonists: leaps of faith or back to the drawing board? Crit Care Med, 1999, 27: 13~14.

共引文献14043

同被引文献18

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部